Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial

Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial

Abstract Background Irritable bowel syndrome (IBS) is one of the most frequent and recurrent gastrointestinal diseases. However, up to now, no pharmacological agent has been approved to treat IBS. Emerging evidence showed that inflammation has a vital role in enhancing nervous system sensitivity and...

Full description

Bibliographic Details
Main Authors: Mahsa Miryan, Pezhman Alavinejad, Mohammadreza Abbaspour, Davood Soleimani, Alireza Ostadrahimi
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
Gastrointestinal diseases
Irritable bowel syndrome
Propolis
Anti-inflammatory agent
Online Access:http://link.springer.com/article/10.1186/s13063-020-04615-5

Internet

http://link.springer.com/article/10.1186/s13063-020-04615-5

Similar Items